Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II.

Breast cancer research and treatment - 1 Jul 2016

Hirko Kelly A, Fortner Renée T, Hankinson Susan E, Wu Tianying, Eliassen A Heather

Abstract excerpt

Findings from epidemiologic studies of oxidative stress biomarkers and breast cancer have been mixed, although no studies have focused on estrogen receptor-negative (ER-) tumors which may be more strongly associated with oxidative stress. We examined prediagnostic plasma fluorescent oxidation products (FlOP), a global biomarker of oxidative stress, and risk of ER- breast cancer in a nested case-control study in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Logistic Models

Share to Oxidative Stress

Share to Public Health Surveillance

Share to Reactive Oxygen Species

Share to Receptors, Estrogen

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 27294610
DOI: 10.1007/s10549-016-3861-5
PMCID: PMC5082691

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II.PMID 27294610Read ↗

Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies.Semantic proximity Read ↗

Circulating Lipid Peroxides Associate with More Aggressive Tumor Phenotypes and Increased Risks of Recurrence and Mortality in Breast Cancer Patients.Semantic proximity Read ↗

Circulating carotenoids and breast cancer among high-risk individuals.Semantic proximity Read ↗

Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.Semantic proximity Read ↗

Plasma Protein Carbonyls and Breast Cancer Risk in Sisters Discordant for Breast Cancer from the New York Site of the Breast Cancer Family RegistrySemantic proximity Read ↗

Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer.Semantic proximity Read ↗

Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer.Semantic proximity Read ↗

Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers.Semantic proximity Read ↗

Urinary phytoestrogens and postmenopausal breast cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.